| Orlistat-associated adverse effects and drug interactions: a critical review TD Filippatos, CS Derdemezis, IF Gazi, ES Nakou, DP Mikhailidis, ... Drug safety 31, 53-65, 2008 | 483 | 2008 |
| Adverse effects of GLP-1 receptor agonists TD Filippatos, TV Panagiotopoulou, MS Elisaf The review of diabetic studies: RDS 11 (3), 202, 2014 | 327 | 2014 |
| Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma I Gazi, ES Lourida, T Filippatos, V Tsimihodimos, M Elisaf, AD Tselepis Clinical chemistry 51 (12), 2264-2273, 2005 | 208 | 2005 |
| Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome TD Filippatosm, CS Derdemezis, DN Kiortsis, AD Tselepis, MS Elisaf Journal of endocrinological investigation 30, 323-326, 2007 | 185 | 2007 |
| Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European … V Kotsis, J Jordan, D Micic, N Finer, DR Leitner, H Toplak, L Tokgozoglu, ... Journal of Hypertension, 2018 | 176 | 2018 |
| Hyponatremia in the elderly: challenges and solutions TD Filippatos, A Makri, MS Elisaf, G Liamis Clinical interventions in aging, 1957-1965, 2017 | 175 | 2017 |
| A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease AA Kei, TD Filippatos, V Tsimihodimos, MS Elisaf Metabolism 61 (7), 906-921, 2012 | 171 | 2012 |
| Statin-associated adverse effects beyond muscle and liver toxicity DN Kiortsis, TD Filippatos, DP Mikhailidis, MS Elisaf, EN Liberopoulos Atherosclerosis 195 (1), 7-16, 2007 | 165 | 2007 |
| A review of the metabolic effects of sibutramine TD Filippatos, DN Kiortsis, EN Liberopoulos, DP Mikhailidis, MS Elisaf Current medical research and opinion 21 (3), 457-466, 2005 | 147 | 2005 |
| Increased plasma visfatin levels in subjects with the metabolic syndrome. TD Filippatos, CS Derdemezis, IF Gazi, K Lagos, DN Kiortsis, AD Tselepis, ... European Journal of Clinical Investigation 38 (1), 71-72, 2008 | 144 | 2008 |
| The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome TD Filippatos, IF Gazi, EN Liberopoulos, VG Athyros, MS Elisaf, ... Atherosclerosis 193 (2), 428-437, 2007 | 137 | 2007 |
| Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study TD Filippatos, DN Kiortsis, EN Liberopoulos, M Georgoula, DP Mikhailidis, ... Current medical research and opinion 21 (12), 1997-2006, 2005 | 133 | 2005 |
| Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia M Kalogirou, V Tsimihodimos, I Gazi, T Filippatos, V Saougos, ... Current medical research and opinion 23 (5), 1169-1176, 2007 | 131 | 2007 |
| Visfatin/PBEF and atherosclerosis-related diseases TD Filippatos, HS Randeva, CS Derdemezis, MS Elisaf, DP Mikhailidis Current vascular pharmacology 8 (1), 12-28, 2010 | 130 | 2010 |
| Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis. DN Kiortsis, AK Mavridis, TD Filippatos, S Vasakos, SN Nikas, AA Drosos The Journal of Rheumatology 33 (5), 921-923, 2006 | 128 | 2006 |
| SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses TD Filippatos, A Liontos, I Papakitsou, MS Elisaf Postgraduate Medicine 131 (2), 82-88, 2019 | 117 | 2019 |
| MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidism-associated hyponatremia: mechanisms, implications and treatment G Liamis, TD Filippatos, A Liontos, MS Elisaf European Journal of Endocrinology 176 (1), R15-R20, 2017 | 110 | 2017 |
| Hyponatremia in patients with heart failure TD Filippatos, MS Elisaf World journal of cardiology 5 (9), 317, 2013 | 107 | 2013 |
| Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study) HJ Milionis, E Rizos, M Kostapanos, TD Filippatos, IF Gazi, ES Ganotakis, ... Current medical research and opinion 22 (6), 1123-1131, 2006 | 105 | 2006 |
| Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education … I Gazi, V Tsimihodimos, T Filippatos, E Bairaktari, AD Tselepis, M Elisaf Metabolism 55 (7), 885-891, 2006 | 104 | 2006 |
Evangelos LiberopoulosNational and Kapodistrian University of Athens在 med.uoa.gr 的电子邮件经过验证
